In this study an email nudge was sent to patients and general practitioners in Denmark. The authors wanted to know if this simple, cheap and pragmatic approach could increase the use of SGLT2i and RASi in patients with diabetic kidney disease.
Do nudges increase the use of GDMT in diabetic CKD?
